Cargando…
What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran
BACKGROUND: The aim of the study is to define the prevalence and antimicrobial susceptibility pattern of bacteria from cases of urinary tract infections (UTIs). MATERIALS AND METHODS: A retrospective analysis of urinary pathogens and their antimicrobial susceptibility was done on urine cultures at S...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781903/ https://www.ncbi.nlm.nih.gov/pubmed/35127579 http://dx.doi.org/10.4103/abr.abr_255_19 |
_version_ | 1784638192117350400 |
---|---|
author | Mahmoudi, Ali Moghadami, Mohsen Shirazi, Babak Tabari, Parinaz Moosavi, Mahsa |
author_facet | Mahmoudi, Ali Moghadami, Mohsen Shirazi, Babak Tabari, Parinaz Moosavi, Mahsa |
author_sort | Mahmoudi, Ali |
collection | PubMed |
description | BACKGROUND: The aim of the study is to define the prevalence and antimicrobial susceptibility pattern of bacteria from cases of urinary tract infections (UTIs). MATERIALS AND METHODS: A retrospective analysis of urinary pathogens and their antimicrobial susceptibility was done on urine cultures at Shiraz University Laboratory from 2015 to 2017. Antimicrobial susceptibility tests have done using the disk-diffusion technique as per the standard of CSLI. RESULTS: During 2 years of study, 3489 samples were culture positive. Escherichia coli was the dominant isolate (84%), followed by Klebsiella spp. (10.7%) and Enterococci spp. (2,2%). The overall resistance rates to trimethoprim-sulfamethoxazole, ceftriaxone, and ciprofloxacin were 56.1%, 47.2%, and 37%, respectively. The most frequently isolated bacteria were E. coli, which had resistance rates of 58.6%, 49.1% to TMP-STX, and cefixime, also sensitivity rates of 95.1% to nitrofurantoin (FM). CONCLUSIONS: In the study area, resistance rates to fluoroquinolones and cephalosporins were high. Because most isolates were sensitive to FM and aminoglycoside, they are suggested as appropriate antimicrobials for empirical treatment of UTIs before available urine culture results. |
format | Online Article Text |
id | pubmed-8781903 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-87819032022-02-04 What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran Mahmoudi, Ali Moghadami, Mohsen Shirazi, Babak Tabari, Parinaz Moosavi, Mahsa Adv Biomed Res Original Article BACKGROUND: The aim of the study is to define the prevalence and antimicrobial susceptibility pattern of bacteria from cases of urinary tract infections (UTIs). MATERIALS AND METHODS: A retrospective analysis of urinary pathogens and their antimicrobial susceptibility was done on urine cultures at Shiraz University Laboratory from 2015 to 2017. Antimicrobial susceptibility tests have done using the disk-diffusion technique as per the standard of CSLI. RESULTS: During 2 years of study, 3489 samples were culture positive. Escherichia coli was the dominant isolate (84%), followed by Klebsiella spp. (10.7%) and Enterococci spp. (2,2%). The overall resistance rates to trimethoprim-sulfamethoxazole, ceftriaxone, and ciprofloxacin were 56.1%, 47.2%, and 37%, respectively. The most frequently isolated bacteria were E. coli, which had resistance rates of 58.6%, 49.1% to TMP-STX, and cefixime, also sensitivity rates of 95.1% to nitrofurantoin (FM). CONCLUSIONS: In the study area, resistance rates to fluoroquinolones and cephalosporins were high. Because most isolates were sensitive to FM and aminoglycoside, they are suggested as appropriate antimicrobials for empirical treatment of UTIs before available urine culture results. Wolters Kluwer - Medknow 2021-12-25 /pmc/articles/PMC8781903/ /pubmed/35127579 http://dx.doi.org/10.4103/abr.abr_255_19 Text en Copyright: © 2021 Advanced Biomedical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Mahmoudi, Ali Moghadami, Mohsen Shirazi, Babak Tabari, Parinaz Moosavi, Mahsa What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran |
title | What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran |
title_full | What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran |
title_fullStr | What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran |
title_full_unstemmed | What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran |
title_short | What Left for Us for Urinary Tract Infection Treatment? An Experience from the South of Iran |
title_sort | what left for us for urinary tract infection treatment? an experience from the south of iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781903/ https://www.ncbi.nlm.nih.gov/pubmed/35127579 http://dx.doi.org/10.4103/abr.abr_255_19 |
work_keys_str_mv | AT mahmoudiali whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran AT moghadamimohsen whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran AT shirazibabak whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran AT tabariparinaz whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran AT moosavimahsa whatleftforusforurinarytractinfectiontreatmentanexperiencefromthesouthofiran |